The shorter isoform of NF-YA also showed greater enrichment in gene signatures than the longer isoform, which potentially indicates its greater susceptibility to carcinogenic activation and thereby more significant involvement in eventual cancer progression. The gene discussed is NFYA; the disease is cancer.